Resource management and capacity planning for clinical trial sites
Background: Since 2020, the number of registered clinical trials has surged by over 30%, significantly increasing the demand for skilled coordinators. Despite this growth, a national shortage of qualified coordinators remains, driven by escalating responsibilities and workloads. Effective resource management is crucial for retention. While the Ontario Protocol Assessment Level (OPAL) helps quantify trial complexity, it overlooks key factors such as organizational structure and budget constraints that impact coordinator productivity. This project aims to refine the OPAL score by integrating it with longitudinal coordinator effort data, improving resource allocation, operational efficiency, and job satisfaction, thereby reducing burnout and turnover.
Aim: The aim of this study was to reduce burnout and turnover, ultimately contributing to the overall success of clinical trials.
Methods: Actively enrolling interventional studies with corresponding coordinator effort tracking from June 1, 2022, to December 1, 2022, were included in the database. Protocols were graded using an adapted protocol assessment tool. Descriptive statistics compared protocol characteristics to the adapted assessment score and tracked coordinator hours, while Student’s t-test and univariate analysis evaluated differences in continuous variables. Linear regression analysis assessed the association between the adapted score and the coordinator effort.
Results: Seven protocols were analyzed: five (71%) were federally funded, two (29%) were industry-sponsored; four (57%) were behavioral interventions, and three (43%) were drug studies. Significant differences were observed between industry-sponsored and federally funded studies (7.25 ± 1.77 vs. 6.45 ± 1.65; P < 0.0001) and between behavioral interventions and drug studies (6.88 ± 1.56 vs. 6.42 ± 1.91; P < 0.0001). Linear regression revealed the adapted OPAL score significantly predicted coordinator hours (β = 77.22; P = 0.01; R2 = 0.78).
Conclusion: The adapted protocol complexity scores predict coordinator effort, aiding in capacity assessment and objective project distribution.
Relevance for Patients: The findings from this project can inform more precise resource allocation, potentially leading to higher-quality studies and enhanced participant safety.
[1] Sun D, Gao W, Hu H, Zhou S. Why 90% of Clinical Drug Development Fails and how to Improve it? Acta Pharm Sin B 2022;12:3049-62. doi: 10.1016/j.apsb.2022.02.002
[2] National Institutes of Health. Trends, Charts, and Maps; 2023. Available from: https://clinicaltrials.gov/ct2/ resources/trends [Last accessed on 2024 Aug 09].
[3] Miessler J. No End in Sight for Trial Complexity, CSDD Report Reveals. CenterWatch; 2022. Available from: https://cms.centerwatch.com/articles/25921-no-endin-sight-for-trial-complexity-csdd-report-reveals [Last accessed on 2024 Aug 09].
[4] Brody AA, Convery KA, Kline DM, Fink RM, Fischer SM. Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations during COVID-19. J Pain Symptom Manage 2022;63:151-9. doi: 10.1016/j.jpainsymman.2021.06.017
[5] Chino F, Zafar SY. Financial Toxicity and Equitable Access to Clinical Trials. Am Soc Clin Oncol Educ Book 2019;39:11-8. doi: 10.1200/EDBK_100019
[6] Buchanan DA, Goldstein J, Pfalzer AC, Lin Y, Kang H, Claassen DO. Empowering the Clinical Research Coordinator in Academic Medical Centers. Mayo Clin Proc Innov Qual Outcomes 2020;5:265-73. doi: 10.1016/j.mayocpiqo.2020.09.014
[7] Lorduy K, Brown V, Rose S. Adapting Productivity Models to Improve Efficiency and Progress in Clinical Research Practice. Clin Res 2020;34: 13-27.
[8] Speicher LA, Fromell G, Avery S, Brassil D, Carlson L, Stevens E, et al. The Critical Need for Academic Health Centers to Assess the Training, Support, and Career Development Requirements of Clinical Research Coordinators: Recommendations from the Clinical and Translational Science Award Research Coordinator Taskforce. Clin Transl Sci 2012;5:470-5. doi: 10.1111/j.1752-8062.2012.00423.x
[9] Kassis S, Winkler S, Gianforti MJ, Needler NA. Research Coordinator Networks and Support Models among Academic Health Centers in the CTSA Consortium. J Clin Transl Sci 2018;1:334-9. doi: 10.1017/cts.2017.309
[10] Getz KA, Wenger J, Campo RA, Seguine ES, Kaitin KI. Assessing the Impact of Protocol Design Changes on Clinical Trial Performance. Am J Ther 2008;15:450-7. doi: 10.1097/MJT.0b013e31816b9027
[11] Richie A, Gamble D, Tavlarides A, Griffin C. Trial Complexity and Coordinator Capacity: The Development of a Complexity Tool. Clin Res 2019;33: 17-23.
[12] Shiely F, Foley J, Stone A, Cobbe E, Browne S, MurphyE, et al. Managing Clinical Trials During COVID-19: Experience from a Clinical Research Facility. Trials 2021;22:62. doi: 10.1186/s13063-020-05004-8
[13] Van Norman GA. Decentralized Clinical Trials. JACC Basic Transl Sci 2021;6:384-7. doi: 10.1016/j.jacbts.2021.01.011
[14] Gohar B, Larivière M, Nowrouzi-Kia B. Sickness Absence in Healthcare Workers during the COVID-19 Pandemic. Occup Med (Lond) 2020;70:338-42. doi: 10.1093/occmed/kqaa093
[15] Richie A, Gamble D, Tavlarides A, Strok K, Griffin C. Establishing the Link Between Trial Complexity and Coordinator Capacity. Clin Res 2020;34:8-16.
[16] Smuck B, Bettello P, Berghout K, Hanna T, Kowaleski B, Phippard L, et al. Ontario Protocol Assessment Level: Clinical Trial Complexity Rating Tool for Workload Planning in Oncology Clinical Trials. J Oncol Pract 2011;7:80-4. doi: 10.1200/JOP.2010.000051
[17] Deglise-Hawkinson J, Kaufman DL, Roessler B, Van Oyen MP. Access Planning and Resource Coordination for Clinical Research Operations. IISE Trans 2020;52:832-49. doi: 10.1080/24725854.2019.1675202
[18] Good MJ, Lubejko B, Humphries K, Medders A. Measuring Clinical Trial-Associated Workload in a Community Clinical Oncology Program. J Oncol Pract 2013;9:211-5. doi: 10.1200/JOP.2012.000797
[19] Morin DJ. Use of Proxy Variables to Determine the Impact of Protocol Complexity on Clinical Research Site Productivity. Ther Innov Regul Sci 2019;53:52-8. doi: 10.1177/2168479018769290
[20] Morin DJ. Harmonizing Protocol Complexity with Resource Management and Capacity Planning at Clinical Research Sites. Ther Innov Regul Sci 2020;54:978-87. doi: 10.1007/s43441-020-00120-8
[21] Fabbri F, Gentili G, Serra P, Vertogen B, Andreis D, Dall’Agata M, et al. How many Cancer Clinical Trials can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool. JCO Oncol Pract 2021;17:e68-76. doi: 10.1200/JOP.19.00386
[22] Lledo L, Johnson C, Chew A, Gilmore B, Dengel K. A Measure to Determine Acceptable Workload for Increasing Operational Efficiencies for the Conduct of Clinical Trials. Doctor of Nursing Practice (DNP) Manuscripts; 2020. Available from: https://dsc.duq.edu/ dnp/1 [Last accessed on 2024 Aug 09].
[23] Wu K, Wu E, D’Andrea M, Chitale N, Lim M, Dabrowski M, et al. Machine Learning Prediction of Clinical Trial Operational Efficiency. AAPS J 2022;24:57. doi: 10.1208/s12248-022-00703-3
[24] Baer AR, Zon R, Devine S, Lyss AP. The Clinical Research Team. J Oncol Pract 2011;7:188-92. doi: 10.1200/JOP.2011.000276
[25] Sarmento R, Silvino Z. Measuring Workload of Clinical Trials: Transcultural Adaptation and Validation to Portuguese Language of Ontario Protocol Assessment Level (OPAL). J Clin Res Bioeth 2017;8:4. doi: 10.4172/2155-9627.1000308
[26] Tyson KT, Morgan-Billingslea J, Taylor T, Khizer S, Parker T, Pemu P. A Single Site Study: Adapting the Ontario Protocol Assessment Level (OPAL). In: Poster presented at: Southeast Regional Clinical & Translational Science Conference, Pine Mountain, GA; 2023.
[27] James P, Bebee P, Beekman L, Browning D, Innes M, Kain J, et al. Effort Tracking Metrics Provide Data for Optimal Budgeting and Workload Management in Therapeutic Cancer Clinical Trials. J Natl Compr Canc Netw 2011;9:1343-52. doi: 10.6004/jnccn.2011.0116
[28] Burgess LJ, Sulzer NU. The Growing Disparity between Clinical Trial Complexity and Investigator Compensation. Cardiovasc J Afr 2010;21:249-50.